miércoles, julio 08, 2015

New biosafety report by GenØk

http://genok.no/arkiv/4294/The new plant breeding techniques provide the emergence of novel products that challenges our current regulations and our management practices of what we traditionally have viewed as a genetically modified organism (GMO).International regulations, such as the Cartagena Protocol on Biosafety, operate with definitions of GMOs that may not be applicable to products arising from some of these new techniques. The question then arises on how society and regulatory bodies should view and regulate the products.This report does not approach that problem per se, but as a crucial step in management, we sum up the current scientific understanding of two new plant breeding techniques, site directed nucleases (SDN) and oligonucleotide directed mutagenesis (ODM). The underlying mode of action of both of these techniques are the plants natural repair systems and how this can be utilized to achieve genomic modifications. Herein also lies the main challenge for risk assessment – our limited knowledge about the function of these systems, factors involved and potential off-target effects.This report aims at providing an overview of the current status of scientific knowledge concerning SDN and ODM. We have reviewed up to date peer reviewed scientific publications on the mechanisms and natural functions that are utilized by SDN and ODM techniques in an effort to understand potential risks such as unintentional changes in the genome of plants. Finally, recommendations for action are outlined.

The new plant breeding techniques provide the emergence of novel products that challenges our current regulations and our management practices of what we traditionally have viewed as a genetically modified organism (GMO).


International regulations, such as the Cartagena Protocol on Biosafety, operate with definitions of GMOs that may not be applicable to products arising from some of these new techniques. The question then arises on how society and regulatory bodies should view and regulate the products.
This report does not approach that problem per se, but as a crucial step in management, we sum up the current scientific understanding of two new plant breeding techniques, site directed nucleases (SDN) and oligonucleotide directed mutagenesis (ODM). The underlying mode of action of both of these techniques are the plants natural repair systems and how this can be utilized to achieve genomic modifications. Herein also lies the main challenge for risk assessment – our limited knowledge about the function of these systems, factors involved and potential off-target effects.
This report aims at providing an overview of the current status of scientific knowledge concerning SDN and ODM. We have reviewed up to date peer reviewed scientific publications on the mechanisms and natural functions that are utilized by SDN and ODM techniques in an effort to understand potential risks such as unintentional changes in the genome of plants. Finally, recommendations for action are outlined.

Etiquetas: , , ,

domingo, septiembre 29, 2013

Proceedings of the International Conference on Modern Biotechnologies: Sustainable Innovation and Regulatory Needs

http://www.biosafety-info.net/article.php?aid=998

September 13, 2013

THIRD WORLD NETWORK BIOSAFETY INFORMATION SERVICE

Dear Friends and Colleagues

Re: Proceedings of the International Conference on Modern Biotechnologies: Sustainable Innovation and Regulatory Needs

The International Conference on Modern Biotechnologies: Sustainable Innovation and Regulatory Needs took place in Penang, Malaysia, on 7-10 November 2012. It was co-organized by GenØk-Centre for Biosafety, Norway and Third World Network.

With the increasing development and use of modern biotechnologies in agriculture, public health and industrial applications, the strengthening of knowledge of and capacity on biosafety is becoming ever more crucial. In light of this urgent need, the Conference was held to build biosafety capacity at both scientific and policy/regulatory levels with a view to improving risk assessment, risk management and policy and regulation related to these technologies, especially in developing countries where resources and capacities are often low.

We are pleased to announce the publication of the proceedings of the Conference, which examines the key issues and main recommendations put forward, within the context of the need to shape scientific research and innovation on modern biotechnologies to prevent or minimize any adverse impacts and to advance the societal interest.

We reproduce below the Executive Summary, which together with the Conference Proceedings can be found at: http://www.biosafety-info.net/pubart.php?pid=77



With best wishes,

Third World Network
131 Jalan Macalister
10400 Penang
Malaysia
Email: twnet@po.jaring.my
Website: http://www.biosafety-info.net/ and http://www.twn.my/

To subscribe to other TWN information services: www.twnnews.net


EXECUTIVE SUMMARY

Reflections from the Organizers

As the developments in modern biotechnology gather pace, so do the challenges for risk assessment, risk management, and policy and regulation related to these technologies. The presentations at the International Conference on Modern Biotechnologies: Sustainable Innovation and Regulatory Needs acknowledged the need to continuously reflect on, update and improve these critical aspects of biosafety, especially given new and emerging applications in diverse fields such as vaccines, insects and microorganisms. It is evident that capacity building and knowledge sharing can play important roles in improving biosafety in all countries, in particular in developing countries.

The issue of sustainability in innovations is also crucial, as the biosafety science and regulatory community needs to collectively take a longer-term and more holistic approach to modern biotechnology development and assessment. Understanding the drivers of research and development, including the current intellectual property system, and re-orienting research and development towards meeting public needs, are important factors to move towards meeting sustainability and public interest goals.

In addition, the presentations at the Conference, in highlighting uncertainties and gaps in scientific knowledge, effectively called for a humbler approach towards science and scientific research, particularly in regard to modern biotechnology. Recognizing the limitations and applying a precautionary approach will help us address the gaps in our scientific knowledge, respect the importance of including traditional knowledge, as well as broaden our options and perspectives. Areas of omitted research should be taken seriously and attention to these gaps can help improve our understanding, assessment and management of genetically modified organisms (GMOs).

Finally, discussing GMOs and modern biotechnology within the wider context of sustainable innovation and sustainable development is absolutely necessary. We believe this should go hand-in-hand with employing a participatory and bottom-up approach towards modern biotechnology and its applications. When these steps are taken, and the full range of alternative options and innovation pathways assessed against a benchmark of meeting needs and for the public good, the choices will become clearer for us all.

Etiquetas: ,

martes, marzo 03, 2009

Biosafety Course and Conference: Hazard ID and Risk Assessment of (Trans)gene Flow

09.02.2009

Course: 17–21 August 2009
Conference: 23-26 August 2009
Venue: GenØk – Centre for Biosafety, Science Park/University of Tromsø/Rica Ishavshotel, Norway


The course will cover:
• a holistic and heuristic approach to risk assessment
• hazard identification
• molecular analyses for predicting flow and its consequences
• pathways of gene flow (microbes, plants and animals)
• introgression pathways
• persistence pathways (selection, linkage, propagule pressure, scale)
• biodiversity and agrobiodiversity
• conservation issues and centres of origin
• consequences of gene flow
o human and animal health impacts
o legal/cultural/social/economic issues
o containment and monitoring
o physical
o biological (GURTs)
• weighing up the costs and benefits of a GMO agroecosystem

Background
The Cartagena Protocol on Biosafety seeks to protect human health and biodiversity from the potential hazards created by the use and dissemination of living “Genetically Modified Organisms” (GMOs), while taking into account socio-economic considerations. Implementation of biosafety regulation is therefore the focus of many countries to establish such safeguards. However, the process of implementing the Protocol has unveiled a limited capacity for science-based hazard identification that is necessary to perform risk assessments, and a holistic understanding of the policy, legal, regulatory, ethical, economic and social dimensions, which is necessary for decision making. In the past 5 years a broad introductory course on hazard identification , risk assessment and biosafety regulation has been offered to fill the capacity gap. Bi-annually over the next 5 years, specialist courses with advanced material will be offered to build beyond the introductory course.

About the course
A critical issue facing most countries is how to manage the coexistence of agroecosystems that use GMOs and those that do not. The flow of transgenes between these different ecosystems—whether within a country or between countries—threatens the non-GMO farmer and consumer that wishes to avoid genetically modified (GM) products. This course will consider the issues created by transgene flow in depth.

The course is designed to provide policy makers, regulators, scientists, journalists and NGOs/civil society leaders, specifically from developing countries (ODA-countries), the knowledge and training necessary to develop a holistic view on the issues surrounding transgene flow and coexistence. The goal is to empower the participants with balanced information on transgene flow, in order to fairly, yet critically, evaluate the issue from their own perspective and country needs. A combination of plenary lectures and interactive sessions, with support from the Biosafety Assessment Tool will form the basis of the course, which aims to offer biosafety capacity building within a holistic framework. Participants will also attend the conference immediately following the Course (23-26 August).

Eligibility and selection process
This course is open to applicants from developing (ODA) countries that have successfully completed one of GenØk’s introductory courses in biosafety (2003-2008), as well as to those who can demonstrate relevant expertise and experience in biosafety work.

The course application form must be filled out entirely and with as much detail as possible. The applicant must provide information about the type/level of position they are holding, and state the basis for their interest in the course. In addition, a brief CV is required for consideration. Applicants for a place in the course must also submit a short abstract related to the topics of the course from which they may be chosen to present a poster or a talk at the associated conference. The working language of the course will be English only, and as such, applicants should be able to work sufficiently well in English in both oral and written communications.

Gender, occupation and regional criteria are used in the selection of participants in order to achieve representational balance. The selection committee usually completes the selection by 1 May.

Applications are due by 1 April 2009.

Costs and expenses
Full sponsorship will be offered to 40 selected applicants from developing (ODA) countries. The sponsorship will cover curricular materials, course-associated travel, visa-fees, accommodation and meals.

Course + conference - self-financed participants
The course has additional 15 places available to participants from all countries that are able to secure their own sponsorship/funding. Previous participation in a GenØk course is not required, but we recommend that the candidate should have extensive experience and expertise in biosafety work in order to benefit fully from the course and conference. The course/conference fee of USD 1000 includes curricular materials, lunch (8 days), opening/farewell ceremony, conference fee, and local transport. In addition, self-financing participants will also have to pay for their travel and accommodation (course/conference hotel NOK 1195/night (approx. US $170) incl. breakfast and dinner buffet). A list of alternative accommodation can be provided. Applications for self-financed places should be submitted no later than 10 June 2009. The places are allocated on a first come first served basis. Participants must be prepared to pay the course fee when registering.

Conference only – self-financed participants
The conference is open to all. For more information and registration see our website www.genok.org where information soon will be announced.

How to apply:

Register online at: http://www.genok.org/application#
Alternatively use this downloadable application form (Word-format).

CV and abstracts should be e-mailed to biosafety09@genok.org

Receipt of application forms will be confirmed by e-mail. Please allow us a few days to repspond.

Contact information:
Project Manager/Adviser Katrine Jaklin
E-mail: katrine.jaklin@genok.org
Phone: +47 77 64 55 46
Fax: +47 77 64 61 00
Web: http://english.genok.org/

Further information about ODA-countries: www.oecd.org/dac/stats/daclist

Etiquetas: , ,

lunes, enero 26, 2009

FULL BIBLIOGRAPHY BELOW


http://www.foodfirst.org/en/node/2345


BIOTECHNOLOGY AND BIOSAFETY: A HOLISTIC VIEW

By Carmelo Ruiz-Marrero



Concerns about the negative impacts of modern biotechnology are scientifically valid and thus do not deserve to be dismissed as ignorance or fear of the unknown. It is quite rare to find spaces, like GenØk, in which the subject of biosafety can be discussed with solid scientific foundations and free of industry pressure. Misgivings about GM foods and products do not constitute opposition to all biotechnology, as the industry claims. What institutions like GenØk advocate is a very cautious and precautionary approach to modern biotechnologies so as to harness the benefits and adequately assess and minimize the risks.

******

GenØk "provides a more holistic perspective on the issue (of modern biotechnology) than other institutions and sets the core gene ecology science in context with some of the underlying technical, economic and social drivers influencing biotechnology and biotechnology regulation", says Peter Johan Schei, leader of Norway's delegation in international biosafety negotiations and GenØk board member. "This is a very ambitious and challenging task, yet one highly needed in a global discourse which often is highly fragmented and where the motives behind argumentation are not always fully obvious."


******

REFERENCES:

Cartagena Protocol on Biosafety http://www.cbd.int/biosafety/

Convention on Biological Diversity http://www.cbd.int/

GenØk http://english.genok.org/

Lim Li Lin, "Progress After Tough Talks on Liability Regime for GMOs," South-North Development Monitor, May 23, 2008, http://www.biosafety-info.net/ article.php?aid=520.

Lim Li Ching and Terje Traavik, eds.
Biosafety First: Holistic Approaches to Risk and Uncertainty in Genetic Engineering and Genetically Modified Organisms, Tapir Academic Press, 2007. Includes collaborations from Lim Li Lin, Arpad Pusztai, Susan Bardocz, David Quist, Tewolde Egziabher and Anne Ingeborg Myhr.

RALLT. Network for a GMO-Free Latin America http://rallt.org/

Smith, Jeffrey, "Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods," Yes! Books, 2007.

Union of Concerned Scientists. "Gone to Seed:
Transgenic Contaminants in the Traditional Seed Supply". 2004. http://www.ucsusa.org/food_ and_agriculture/science_and_ impacts/impacts_genetic_ engineering/gone-to-seed.html

Etiquetas: , , ,